EP2430183
ANTIPSYCHOTIC TREATMENT BASED ON DRD2 OR ANKK1 SNP GENOTYPE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.5.2010EP published:
17.12.2014EP application number:
10719224.7
EPO information:
European Patent Register
Max expiry date:
14.5.2030
Title:
ANTIPSYCHOTIC TREATMENT BASED ON DRD2 OR ANKK1 SNP GENOTYPE
Timeline
Today
15.5.2010EP application
17.12.2014EP Publication
Owner
Name:
Vanda Pharmaceuticals Inc.Address:
2200 Pennsylvania Avenue Suite 300-E, 20037, Washington, DC, US
Inventor
Name:
LAVEDAN, ChristianAddress:
PotomacMD, US
Name:
VOLPI, SimonaAddress:
DerwoodMD, US
Priority
Number:
178934 PDate:
15.5.2009Country:
US
Classification
Categories:
C12Q 1/68, A61P 25/18